1. Home
  2. ENTA vs GRRR Comparison

ENTA vs GRRR Comparison

Compare ENTA & GRRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$13.16

Market Cap

374.6M

Sector

Health Care

ML Signal

HOLD

Logo Gorilla Technology Group Inc.

GRRR

Gorilla Technology Group Inc.

HOLD

Current Price

$20.39

Market Cap

419.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTA
GRRR
Founded
1995
2001
Country
United States
United Kingdom
Employees
N/A
200
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
374.6M
419.5M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
ENTA
GRRR
Price
$13.16
$20.39
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$20.40
N/A
AVG Volume (30 Days)
199.8K
940.8K
Earning Date
05-11-2026
06-17-2026
Dividend Yield
N/A
N/A
EPS Growth
29.93
N/A
EPS
N/A
N/A
Revenue
$102,814,000.00
N/A
Revenue This Year
$7.76
$69.35
Revenue Next Year
N/A
$85.38
P/E Ratio
N/A
N/A
Revenue Growth
16.48
N/A
52 Week Low
$5.88
$9.04
52 Week High
$17.15
$27.90

Technical Indicators

Market Signals
Indicator
ENTA
GRRR
Relative Strength Index (RSI) 41.92 80.51
Support Level $13.00 $11.63
Resistance Level $13.76 $22.43
Average True Range (ATR) 0.72 1.18
MACD -0.13 0.53
Stochastic Oscillator 8.71 99.88

Price Performance

Historical Comparison
ENTA
GRRR

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About GRRR Gorilla Technology Group Inc.

Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments. Its expertise lies in revolutionizing urban operations, enhancing security, and optimizing digital transformation. It delivers pioneering products that integrate AI, deep learning, and edge computing to advance intelligent video surveillance, facial recognition, license plate recognition, post-event analytics, cybersecurity, and network intelligence.

Share on Social Networks: